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Abstract
The present work aimed to verify the effects of  Baypamun®HK on
the survival of  albinic mice, experimentally infected with Toxoplasma
gondii RH strain, treated or not with sulfadiazine-pirimetamine, as well
as on the formation and the number of brain cysts. Four groups of 20
mices were inoculated with 105 tachizoites, subcutaneously, and
undergone to different treatments. Serum tests were carried out by
indirect immunofluorescence and samples of  brain, liver and lung
were collected from animals who died for cytological and brain cysts
examinations. After 60 days, all survivors were sacrificed. Isolated
Baypamun®HK didn’t present a protective action against the infection
by T. gondii, but its association sulfadiazine-pirimetamine, a specific
treatment caused a higher survival of  animals and a more intense and
longer antibody responses.
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Introduction
Non-specific immunological
stimulation is named paraimmunization and
corresponds to an  immunological status
independent from the contact of  the immune
system with specific pathogens.1,2 The
activation of  systems involved in
paraimmunity may occur naturally by the
contact with infectious agents or generated
artificially by the administration of
paraimmunity inductors.3
Paraimmunizer agents activate the
production of  humoral factors, like the
interferons, mediators like interleukin and the
tumour necrosis factor, the complement
systems and lyzosime and also cellular
factors, like macrophages, natural killer cells,
T and B lymphocytes, being that many of
these components are involved in the
establishment of  the specific immunity.2,4,5,6
Thus the induction of paraimmunity is
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indicated in all cases in which
immunoprophylaxis or chemiotherapy aren’t
enough to control infections.2
The utilization of BCG seems not to
improve the response to the infection by
Toxoplasma gondii. Dubey7 studied the
reexcretion of  oocysts of  T. gondii in
superinfected cats, where the administration
of BCG before the infection seemed
ineffective over the re-excretion of  the
oocysts. Rezai et al.8 paraimmunized mice
with BCG and, 17 days after, inoculated a
virulent strain of  T. gondii. Animals presented
incomplete resistance, but survived
considerably longer than non-
paraimmunized controls.
Intravenous pre-treatment of  mice
with Corynebacterium par vum showed a
temporary protection in animals challenged
with non-virulent strains of  T. gondii, but not
when infected with virulent strains.
Peritoneal macrophages were activated,
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Materials and Methods
Eighty Swiss mice 21-day-old were
used, divided into 4 groups of  20 animals,
being: group 1 (Gl), control, represented by
animals treated neither with Baypamun®HK *
nor with sulfadiazine-pirimetamine; Group
2 (G2), treated with Baypamun®HK only;
Group 3 (G3), treated with sulfadiazine-
pirimetamine only; and Group 4 (G4), treated
with Baypamun®HK and sulfadiazine-
pirimetamine.
For the experimental infection T.
gondii RH strain was used and tachizoites
were obtained by mice peritoneal flushes
seven days after inoculation. The inoculum
obtained from this flushes was adjusted to a
concentration of 1 x 105 tachizoites/mL.
Two days after blood collection, via
orbital sinus for serological examination,
Results and Discussion
Animals from groups G1 and G2 died
between seven and nine days and three and
eight days after the inoculation with T. gondii,
with an average from 7.70 and 6.85 days,
respectively. In groups G3 and G4 only seven
and two animals died, respectively and,
among these, no one presented signs of  the
destroying Toxoplasma in vitro, being that the
population of activated macrophages
persisted even in animals in which protection
was temporary.9 McLeod and Remington10
studying the ability of peritoneal
macrophages of mice in responding to the
infection by T. gondii verified that in mice
treated with C. parvum these cells efficiently
destroyed the parasite.
Parapoxvirus ovis (strain D1701),
isolated agent of  epitelial pustules of  sheep,
is recognizably an activator of  paraimmunity,
being the active component of
Baypamun®HK (Baypamun®HK, Bayer
Saúde Animal), a largely used product used
nowadays in prophylaxis and as a coadjuvant
in the specific treatment of a number of
infectious diseases and immunodepressive
conditions, such as stress and neoplasias.
There is no register in literature of the
use of Baypamun®HK as a paraimmunizer
in infections by T. gondii. The present work
aimed to verify the effects of Baypamun®HK
on the survival of  albinic mice experimentally
infected with T. gondii RH strain, treated and
no treated with sulfadiazine-pirimetamine, as
well as on the formation of  tissue cysts of  T.
gondii in the brain.
mice were subcutaneously inoculated with 1
mL of the inoculum, containing l x l05
tachizoites.
Animals from groups G2 and G4
were orally treated with sulfadiazine-
pirimetamine (Fanzidar®), in the dose of  20
mg of sulfadiazine and 1 mg of pirimetamine
plus 1 g of sodium bicarbonate (NaHCO3)
to each 100  mL of drinkable water,
between the days two and fifteenth after
infection, according to Villard et al..11
Mice were observed twice a day for
sixty days and blood samples were collected,
via orbital sinus, for serological examination
at 0, 3, 10, 17, 24, 31, 38, 45, 52 and 59 after
the infection. Indirect fluorescent antibody
test (IFAT) was carried out according to
Camargo12, up 1/16 dilution and in ratio 4
until the extinction of the serological
reaction. From animals that died and from
the ones that were sacrificed at the end of
the observation period, samples of  liver,
lungs and brain were collected for cytological
examination by Giemsa coloration.
One half  of  each brain collected was
crushed and homogenized with 0,5 mL of
phosphate buffered saline (PBS), being 25
mL examined between glass slides of 22x22
mm to count the total number of  tissue cysts.
The average of  the total number of  cysts
counted in three laminas was multiplied by
the correction factor 20.13
The results of  the serological
examination of  groups G3 and G4 were
analyzed by the Mann-Whitney test and data
obtained in cytological and brain cysts
counting examinations, as well as the survival
of  the animals, were compared by the
Kruskal-Wallis test.14
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Table 1
Average and median of the infection degree (number of tachizoites in 20 microscopic fields) of mice of groups G1 and G2, in the different organs
evaluated. Botucatu, 2003
Table 2
Average and median of the number of tissue cysts of Toxoplasma gondii(corrected value) in brains of mice from groups G3 and G4. Botucatu, 2003
disease.
There was no statistical significance
between groups G1 and G2 (p>0.05) and
between G3 and G4 (p>0.05) regarding to
the animal survival, indicating that this higher
number of animals of groups G3 (average
49.90 days) and G4 (55.65 days) was due to
the effects of the specific treatment.
Serological examinations carried out
in animals from groups G1 and G2 showed
that none of  these were serum converted.
There was no statistical significance between
the serological response of  mice from groups
G3 and G4. However, it must be emphasized
that, in G3, only 50% of  animals were serum
converted and, from these ones, 40%
presented serological reaction in more than
one sample, while, in G4, 75% of  animals
were serum converted, with 73.3% of
serological reactions in more than one
sample, indicating a possible stimulation of
Baypamun®HK over the formation of
antibodies.
The cytological examination of  the
tissue samples of  mice from groups G1
showed different degrees of  infection with
average from 0.45, 1.65 and 19.20 tachizoites
in 20 microscope fields in the brain, lung and
liver, respectively. For the group G2 the
average were 1.15, 9.40 and 28.50,
respectively, in the same organs (Table 1). In
the groups G3 and G4 parasitic forms were
not found in none of  the organs examined,
even in those which died before the end of
the observation period.
The direct examinations of the
crushed brain of mice who died were
negative in all 40 animals of groups G1 and
G2. On the other hand, the cyst counting of
T. gondii in the brain of the mice of groups
G3 and G4 revealed not significantly
different (p>0.05) (Table 2).
Baypamun®HK did not show a
protective effect over the infection of  mice
with Toxoplasma gondii; however, when
associated to the specific treatment with
sulfadiazine-pirimetamine it increased the
survival of  animals, inducing the formation
of  specific antibodies in higher number of
mice. It shows a more effective and intense
cellular stimulation, once these animals also
presented higher antibodies titles when
compared with the ones of the group which
received only sulfadiazine-pirimetamine.
The protective effects of Baypamun HK in mice experimentally infected with Toxoplasma gondii
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Resumo
O presente trabalho teve como objetivo verificar os efeitos do
Baypamun®HK sobre a sobrevida de camundongos albinos,
experimentalmente infectados com Toxoplasma gondii amostra RH,
submetidos ou não ao tratamento com sulfadiazina-pirimetamina,
bem como sobre a formação e número de cistos cerebrais. Quatro
grupos de 20 camundongos foram inoculados com 105 taquizoítos,
via subcutânea, e submetidos a diferentes tratamentos. Os testes
sorológicos foram realizados pela técnica de imunofluorescência
indireta, e, dos animais que sucumbiram, amostras de cérebro, pulmão
e fígado foram retiradas para exame citológico e de cérebros para a
pesquisa de cistos. Ao final de 60 dias todos os sobreviventes foram
sacrificados. Isoladamente o Baypamun®HK não apresentou uma
ação protetora contra a infecção pelo T. gondii, mas sua associação com
o tratamento específico pela sulfadiazina-pirimetamina promoveu
maior sobrevida dos animais e uma resposta de anticorpos mais
intensa e duradoura.
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The cellular activity and the
production of citocines was not studied at
this moment, but the serological result shows
the possibility of Baypamun®HK as a
potentiator in the treatment of toxoplasmosis
and, also, as a possible adjuvant of  vaccines
against this parasite. In conclusion,
Baypamun®HK, alone, did not show a
protective effect in mice experimentally
infected with T. gondii, RH strain; however,
when associated with sulfadizine-
pirimetamine, it provided a higher animal
survival and a more intense and longer
antibody responses.
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